Return to search results
Insulin human
Myxredlin is a prescription intravenous solution containing insulin human, manufactured by Baxter Healthcare Corporation. It provides 1 unit of insulin per milliliter and is used to manage blood sugar levels in patients with diabetes. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Myxredlin is a prescription intravenous solution containing insulin human, manufactured by Baxter Healthcare Corporation. It provides 1 unit of insulin per milliliter and is used to manage blood sugar levels in patients with diabetes. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Insulin human",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Insulin human — ANDA 019717 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019717"
}
]
|
| identifier | ANDA019717 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-manufacturers",
"fda",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Insulin human |
